Stay updated on High Dose Cytarabine + Pembrolizumab in AML Clinical Trial

Sign up to get notified when there's something new on the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    This change updates the page's underlying version from v3.6.4 to v3.6.5, indicating a small maintenance update to the template or platform without modifying the study details.
    Difference
    0.1%
    Check dated 2026-08-11T17:59:09.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page shows a revision tag updated from v3.6.3 to v3.6.4, indicating a minor software update to the underlying system. This is a technical version bump and does not change the clinical trial details or visible content.
    Difference
    0.1%
    Check dated 2026-07-28T10:53:08.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The revision label was updated from v3.6.0 to v3.6.3, indicating a minor update to the document history. The change reflects a version bump rather than a substantive modification to the study details.
    Difference
    0.1%
    Check dated 2026-06-30T00:42:13.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page now shows a recruitment status, and adds guidance sections for reading the study record and joining the study. The Interventions/Treatment label is reformatted and the revision tag updated from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-15T18:57:16.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.5, replacing Revision: v3.5.4, indicating a minor version update to the page's documentation/markup rather than substantive study information.
    Difference
    0.1%
    Check dated 2026-06-08T16:22:21.000Z thumbnail image
  9. Check
    101 days ago
    Change Detected
    Summary
    New revision tag v3.5.4 was added, replacing the previous v3.5.3. This reflects an update to the page’s release/version labeling rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-05-18T03:49:57.000Z thumbnail image

Stay in the know with updates to High Dose Cytarabine + Pembrolizumab in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page.